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Background. Lung transplantation remains the only viable option for patients with
end-stage lung diseases. However, due to an insufficient number of lung donors, many
potential candidates die without undergoing the procedure. In the cases of some
patients, bridges to transplantation can be implemented. One such method is
extracorporeal membrane oxygenation (ECMO), which, depending on the type, has the
ability to replace patients’ circulatory and respiratory function.
Case presentation. This case study describes 4 cases of patients, who were successfully
bridged to lung transplantation. The first patient developed respiratory failure as a result of
acute pulmonary embolisms. His respiratory function was insufficient and he had ECMO
implanted for 84 days until he was transplanted. Another patient presented respiratory failure
due to massive bleeding, which occurred during transbronchial lung biopsy. Such event led to
extensive exacerbation, which resulted in using ECMOas a bridge to recovery at first, but later
a bridge to lung transplantation. The patient became a lung graft recipient after 14 days on
ECMO. The third patient was a woman who developed severe respiratory failure during the
course of the progression of her underlying disease. She was treatedwith ECMO for 14 days as
well, and she also underwent lung transplantation. The fourth patient was qualified for
retransplantation. She was bridged to retransplantation via veno-venous ECMO.
Conclusion. ECMO can be used a bridge to lung transplantation for suitable patients
even for a long period of time, given that it is maintained in accordance with the guidelines.*Address correspondence to Magdalena Latos, MD, Medical
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þ48667288893. E-mail: latos.magdalena93@gmail.comEXTRACORPOREAL membrane oxygenation (ECMO)provides respiratory or cardiorespiratory support for
critically ill patients. It is estimated by the Extracorporeal Life
Support Organization Registry that this device helped more
than 65,000 patients worldwide since 1989 [1,2]. Two main
modes of ECMO include veno-venous (VV) and veno-
arterial (VA). The first one is used for patients in critical
respiratory failure. Additional impairment of circulation re-
quires the veno-arterial one. ECMO is applicable among
children and adults. Since it has been implemented for the
first time 40 years ago, it has evolved from a device associated
with poor patient outcome and frequent complication to one
of the leading bridges to recovery from pulmonary failure or
as a bridge to lung transplantation [3]. This change was
possible due to technical advancements, as well as advancing0
rg/10.1016/j.transproceed.2020.02.114knowledge about such devices over the years. ECMO can be
safely used for extended periods of time to optimize critically
ill patients [4]. In case of lack of respiratory improvement
among patients already qualified, or at least during qualifi-
cation to lung transplantation, bridging to transplantation by
means of ECMO can provide satisfactory results. However,
this procedure requires thorough management, which is
considered challenging [5]. It was reported that one of the
longest successful bridge to transplantations lasted 107 daysª 2020 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
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ECMO AS A BRIDGE TO LUNG TRANSPLANTATION 2111[6]. Recent studies report that although implemented by an
experienced team, results of lung transplantation do not differ
in comparison to patients who did not require such support
before transplantation [7e9]. The aim of this study was to
assess the 4 cases of patients bridged to lung transplantation
by means of ECMO in a single center.
CASE SERIES PRESENTATION
Three out of the 4 patients were bridged to primary lung
transplantation. The remaining patient was a previous single
lung recipient awaiting retransplantation.
Patient Number 1
A 42-year-old male patient was admitted to the Silesian
Center for Heart Diseases due to massive acute pulmonary
embolism. At admission, he was hemodynamically unstable
and required urgent cardiothoracic surgery. Additionally he
suffered from impaired glucose tolerance, mild liver disease,
and acute renal failure. After embolectomy, there was se-
vere bleeding to the right bronchus. As other interventions
failed to stop the hemorrhage, it was decided to make a
resection of the middle lobe. ECMO VA was implemented
due to symptoms of right ventricle failure unresponsive to
pharmacologic treatment. After a few days, ECMO VA was
weaned off. The patient remained on mechanical ventilation
and medium doses of catecholamine, and he had his diuresis
pharmacologically forced. A couple of days later, arterial
blood gases showed progressively worse results. The patient
was diagnosed with respiratory failure and ECMO VV was
implemented. As the patient was awake and there was a
slight chance of recovery, the qualification process for lung
transplantation was initiated. The patient was qualified, and
after 90 consecutive days spent on ECMO VV he became a
single left lung recipient due to complete paralysis of the
right phrenic nerve. Due to the long time spent in the
horizontal position without a chance of proper movement,
the patient required 2 weeks of respiratory support by
means of mechanical ventilation via tracheostomy, as well as
intense rehabilitation. He was then discharged after 3 weeks
in general good condition.
Patient Number 2
A 48-year-old male patient who became a double lung
transplant recipient due to respiratory failure developed
advanced nonspecific interstitial pneumonia complicated by
massive bleeding during transbronchial lung biopsy. It was
reported that he had a history of chronic sinusitis as and had
underwent 2 procedures, right hip joint arthroplasty due to
necrosis of the femoral head and nasal septum correction
with polypectomy of the maxillary sinuses 5 and 6 years prior
to lung transplantation, respectively. The first signs of inter-
stitial lesions were described as patchy densifications at hilar
level, as they were visible on chest radiograph in 2015. The
patient was re-admitted as his pulmonary symptoms intensi-
fied (dyspnea, decreased exercise tolerance). In April 2018,
the patient noticed sudden shortness of breath withparoxysmal cough while running after a several months-long
break from physical activity. Various biochemical assessment
and noninvasive test were not able to determine the exact
type of the disease. It was decided by his primary care pul-
monology department to perform a biopsy. During hospi-
talization, bronchoscopy was performed. Unfortunately, this
procedure was complicated with massive bleeding, which led
to exacerbation of the underlying disease. Due to developing
respiratory failure, the patient was transferred to intensive
care unit (ICU), where he was intubated. No progress was
noted, so our facility was contacted for potential qualification
to lung transplantation. Due to the patient’s deteriorating
state the decision was made to introduce ECMO as a bridge
to transient recovery or to lung transplantation. Three out of
4 lung transplantation centers in Poland refused to perform
such transplantation, especially that suspicion of coronary
artery disease has been raised (calcium score of 800 in pre-
viously performed chest computed tomography). The deci-
sion was made to transfer the patient by an aircraft to the
Silesian Center for Heart Disease in Zabrze after introducing
an ECMO device by the team of prof. P. Suwalski from
Ministry of Interior and Administration hospital in Warsaw.
After transferring the patient to our center, the angiocor-
onarography was performed on the patient with implanted
working ECMO, and coronary artery disease was ruled out.
Bronchoscope interventions performed for the next 2 weeks,
as well as optimal ventilation during working ECMO, did not
bring desired result (lungs did not regain their functional
status). Repeated attempts to reduce respiratory support by
ECMO failed (defined as rapid desaturation). Therefore, the
decision was made to begin the qualification process for lung
transplantation due to pulmonary fibrosis. After 2 weeks of
such treatment a matching donor was reported. Double lung
transplantation took place. He was discharged after a few
weeks in good general condition. He reached 1-year survival
last month.
Patient Number 3
A 24-year-old female patient was admitted in April 2019 in
general stable condition in order to begin the process of
qualification for lung transplantation. She was oxygen
dependent. She was to be qualified for lung transplantation
due to severe graft-vs-host disease, which she developed
after hematopoietic stem cells transplantation due to leu-
kemia, which she suffered from 8 years prior to qualifica-
tion. This type of graft-vs-host disease patient suffered from
attacks on few organs, but the biggest impairment and loss
of function was associated with the lungs. Prior to her first
visit in this facility, she was diagnosed with recurrent bilat-
eral pulmonary edemas treated with pleurodesis. She un-
derwent several lung resections. She was consulted by a lung
transplant facility in Vienna, where she was disqualified due
to severity of her condition. She was initially qualified for
lung transplantation in May. Soon after, her condition
worsened as she was hospitalized in the ICU. When invasive
mechanical ventilation did not provide satisfactory results,
the decision was made to apply ECMO VV in the ICU. The
2112 STĄCEL, URLIK, ANTONCZYK ET ALpatient was then transported on ECMO VV to our facility,
where she was awaiting lung transplantation for 14 days in
an awake state. She was under constant supervision of
medical professionals and psychologists. She underwent
double lung transplantation complicated with severe
hemostatic disorders. She died at the end of the procedure.
Nevertheless, she was given a chance at surviving by suc-
cessful bridging to transplantation.
Patient Number 4
A 41-year-old female who underwent single left lung trans-
plantation due to hypersensitivity pneumonitis was the next
patient. At the time of the initial procedure, right lung
transplantation was withdrawn due to suspicion of massive
pleural adhesions. In the post-transplant course, she devel-
oped chronic rejection, as well as frequent infections from
pathogens, whichwas difficult to eradicate due to significantly
destroyed tissue of the native lung. Her state got worse after
1.5 years after primary transplantation. She became oxygen
dependent and her arterial blood gases revealed total respi-
ratory failure. She underwent extensive testing enabling
qualification to retransplantation. Even though she was
qualified at the right moment, her rare blood type (B), short
height, and restrictive lung disease made finding the proper
donor difficult.Due to her deteriorating state, shewas treated
with mechanical ventilation, which did not provide satisfac-
tory results. She had ECMO VV implemented and was
awaiting an available donor. This was reported after 2 days on
ECMO. She underwent double lung transplantation. Due to
hemostatic problems connected to right pleura, she had to be
reoperated on. Her state was improving. Unfortunately, later
in the early post-transplant period she underwent sudden
cardiac arrest with cardiopulmonary resuscitation lasting
more than an hour with final application of ECMO VA. The
patient was successfully weaned of such support with good
general cardiac function but in need of mechanical ventila-
tion. After sudden cardiac arrest she did not regain con-
sciousness and died after a month.DISCUSSION
This study describes the first cases of successful bridging to
lung transplantation in Poland. It is reported that patients,
who are in need of ECMO as a bridge to lung trans-
plantation present the ultimate respiratory failure. All of the
patients described in our study were successfully bridged to
lung transplantation. As it was reported by Zwischenberger,
in the one of the most experienced ECMO facilities only
74% of patients with severe respiratory failure were weaned
from ECMO and 64% survived to hospital discharge. This
way of treatment can increase a chance for lung trans-
plantation as an ultimate bridge, but also has very serious
complications. Patient number 3 experienced the most
common onedhemostatic disorders. That is why thorough
management by an experienced team is required. A study
published by Tipograf et al presents German experience
with this method of bridging [7]. Their results prove thatpatients bridged with ECMO can provide survival results
not statistically different from those who did not require
such assistance before transplantation. This finding is also
supported by results published by 2 American lung trans-
plant programs. Halpern et al report that patients under-
going bridging to transplantation by means of ECMO at
centers that perform more than 35 lung transplantations
annually have equivalent mortality to those who do not
require ECMO before transplantation [8]. This result is
particularly encouraging, as this year (2019) our team
reached 35 lung transplantations for the first time in the
history of the entire lung transplant program of Silesian
Center for Heart Diseases in Zabrze. Another American
research team led by Hakim also confirmed that ECMO
support before transplantation will not lead to worse results
[9]. They also point out the importance of careful selection
of potential ECMO candidates, as well as early imple-
mentation in order to preserve patients’ vitality by exercising
with a physiotherapist, proper feeding, and so on.
CONCLUSIONS
This case series reports the first 4 successful cases of bridging
to lung transplantation in Poland. As the experience of this
lung transplant program grows, we are encouraged by results
of the high-volume programs to continue this way of bridging
to lung transplantation.REFERENCES
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